Summit Therapeutics, Inc. · 2 weeks ago
Senior Manager/Associate Director, Portfolio Strategy & Market Research
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life and addressing serious unmet medical needs. The Sr Manager/Associate Director, Portfolio Strategy & Market Research will support strategic planning activities by providing actionable recommendations based on market and competitor assessments.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Deliver strategic market and competitive intelligence insights through research, scenario planning, and impact assessments to guide executive decision-making and portfolio strategy
Conduct deep analysis of competitors, products, and market trends, maintaining real-time awareness of landscape changes and translating insights into strategic implications
Develop, lead and execute comprehensive market research plans (qualitative, quantitative, and competitive), selecting vendors, designing studies, interpreting results, and ensuring timely, high-quality deliverables
Inform forecasting and revenue modeling for new indications up to 18 months before launch, providing data-driven assumptions for early commercial planning
Integrate market research and intelligence into strategic planning, including brand plans, market access, and situation analysis
Maintain an in-depth understanding of oncology markets and data sources, synthesizing findings into a central Knowledge Repository for organizational use
Partner cross-functionally with Commercial, R&D, Corporate Strategy, Regulatory, and Operations to align insights with portfolio priorities and address emerging business challenges
Provide ad hoc analytical support to executive stakeholders to inform R&D, commercial, and business development decisions
Leverage best-in-class analytical methodologies and tools to interpret epidemiology, market, and customer data into actionable recommendations
Build and manage external partnerships—from market research vendors to data providers—ensuring quality, accountability, and cost-effectiveness
Qualification
Required
Bachelors Degree in Biotech or related field
Minimum of 8+ years of pharmaceuticals/biotech industry experience working with both qualitative and quantitative research in oncology/pharma market with emphasis on Non-Small Cell Lung cancer and other Solid Tumors is required
Strong understanding of the Solid Tumor Oncology landscape, including market planning, competitive intelligence, forecasting, and key therapeutic areas such as lung cancer
Proven ability to identify and collect relevant market, customer, and competitor data; perform quantitative and qualitative analysis; and translate complex findings into actionable market insights and strategic recommendations
Experience developing and executing primary and secondary market research
Proven experience leading, managing and executing end-to-end market research: designing research plans, synthesizing findings/insights, presenting, etc
Experience with advanced spreadsheets, patient-based forecast modeling including dynamic patient models, NPV modeling
Use online market research and catalogue findings to databases
Strong communication and presentation skills
Skilled at PowerPoint, Excel and similar data tools
Ability to travel up to 25% of the time, depending on business needs
Preferred
Advanced degree preferred
Exposure to global markets preferred
Experience in facilitating competitive workshops, well-versed in TPP development with program and study teams is a plus
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Recent News
2025-12-09
2025-12-05
Company data provided by crunchbase